Search research articles
Contact Us
Filters
Showing results (141-150 of 208) with videos related to
Page
of 21
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)
|
November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
Pedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Blood
|
February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Blood
|
May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemia
Xinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
British Journal of Haematology
|
November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Meaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology
|
July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
Francesca Gay, S Vincent Rajkumar, Morton Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 15, 2014
Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing
Winnie S Liang, Jessica Aldrich, Sara Nasser, et al.
Leukemia
|
July 21, 2018
Spectrum and functional validation of PSMB5 mutations in multiple myeloma
Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 25, 2017
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma
Erik H van Beers, Martin H van Vliet, Rowan Kuiper, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 208) with videos related to
Sort By:
Page
of 21
Cancer Prevention Research (Philadelphia, Pa.)
|
November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study
Pedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Blood
|
February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Blood
|
May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemia
Xinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
British Journal of Haematology
|
November 24, 2011
A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
Meaghan L Khan, Craig B Reeder, Shaji K Kumar, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
American Journal of Hematology
|
July 21, 2010
Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma
Francesca Gay, S Vincent Rajkumar, Morton Coleman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 15, 2014
Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing
Winnie S Liang, Jessica Aldrich, Sara Nasser, et al.
Leukemia
|
July 21, 2018
Spectrum and functional validation of PSMB5 mutations in multiple myeloma
Santiago Barrio, Thorsten Stühmer, Matteo Da-Viá, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 25, 2017
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma
Erik H van Beers, Martin H van Vliet, Rowan Kuiper, et al.
Page
of 21